These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Rho-kinase inhibition in the therapy of cardiovascular disease. Lai A; Frishman WH Cardiol Rev; 2005; 13(6):285-92. PubMed ID: 16230885 [TBL] [Abstract][Full Text] [Related]
5. Rho kinase as potential therapeutic target for cardiovascular diseases: opportunities and challenges. Hu E; Lee D Expert Opin Ther Targets; 2005 Aug; 9(4):715-36. PubMed ID: 16083339 [TBL] [Abstract][Full Text] [Related]
6. [Role of the Rho/Rho-kinase pathway in the development of hypertensive glomerulosclerosis: renoprotective effect of Rho-kinase inhibitor in hypertensive glomerulosclerosis and its molecular mechanism]. Nishikimi T Nihon Yakurigaku Zasshi; 2006 Sep; 128(3):153-9, 152. PubMed ID: 16971778 [No Abstract] [Full Text] [Related]
7. Simvastatin elicits dilation of isolated porcine retinal arterioles: role of nitric oxide and mevalonate-rho kinase pathways. Nagaoka T; Hein TW; Yoshida A; Kuo L Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):825-32. PubMed ID: 17251484 [TBL] [Abstract][Full Text] [Related]
8. Rho-kinase as a potential therapeutic target for the treatment of pulmonary hypertension. Xing XQ; Gan Y; Wu SJ; Chen P; Zhou R; Xiang XD Drug News Perspect; 2006 Nov; 19(9):517-22. PubMed ID: 17220956 [TBL] [Abstract][Full Text] [Related]
9. Rho-kinase inhibitor may exert a role in preventing cardiac hypertrophy, independent of antihypertensive effects. Pan M; Jing HM; Zhu JH; Liu ZH; Jiang WP; Yang XJ Med Hypotheses; 2007; 68(1):234. PubMed ID: 16919397 [No Abstract] [Full Text] [Related]
10. Inhibition of RhoA/Rho-kinase pathway suppresses the expression of type I collagen induced by TGF-beta2 in human retinal pigment epithelial cells. Itoh Y; Kimoto K; Imaizumi M; Nakatsuka K Exp Eye Res; 2007 Mar; 84(3):464-72. PubMed ID: 17217948 [TBL] [Abstract][Full Text] [Related]
14. Targeting Rho and Rho-kinase in the treatment of cardiovascular disease. Budzyn K; Marley PD; Sobey CG Trends Pharmacol Sci; 2006 Feb; 27(2):97-104. PubMed ID: 16376997 [TBL] [Abstract][Full Text] [Related]
15. Discovery and initial SAR of inhibitors of interleukin-1 receptor-associated kinase-4. Powers JP; Li S; Jaen JC; Liu J; Walker NP; Wang Z; Wesche H Bioorg Med Chem Lett; 2006 Jun; 16(11):2842-5. PubMed ID: 16563752 [TBL] [Abstract][Full Text] [Related]
16. Progress of the study of rho-kinase and future perspective of the inhibitor. Tawara S; Shimokawa H Yakugaku Zasshi; 2007 Mar; 127(3):501-14. PubMed ID: 17329936 [TBL] [Abstract][Full Text] [Related]
17. Rho-kinase inhibitors show promise in pulmonary hypertension. Doggrell SA Expert Opin Investig Drugs; 2005 Sep; 14(9):1157-9. PubMed ID: 16144499 [TBL] [Abstract][Full Text] [Related]
19. Statins could be new treatment option in women with oestrogen receptor positive breast cancer. Kmietowicz Z BMJ; 2016 Jun; 353():i3108. PubMed ID: 27257183 [No Abstract] [Full Text] [Related]
20. ROCKs as therapeutic targets in cardiovascular diseases. Rikitake Y; Liao JK Expert Rev Cardiovasc Ther; 2005 May; 3(3):441-51. PubMed ID: 15889972 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]